European Society of regulatory Affairs

The European Society of regulatory Affairs is an independent organization dedicated to deliver up-to-date coaching programme on regulatory affairs and drug development, with a spotlight on biopharmaceutical-related regulatory affairs in Europe. The European Society of regulatory Affairs is devoted group to European regulatory affairs within the regulatory Affairs field.

The European Society of regulatory Affairs deals with clinical trials and all drug safety and regulatory activities, also as potential job vacancies concerned in these lines of work.

We welcome many different backgrounds and attempt to network all regulatory professionals concerned in these areas. European Society of regulatory Affairs formed because there was a scarcity of an adequate training platform specifically on biopharmaceutical-related regulatory affairs and drug development. based on an intensive dialogue with key stakeholders from authorities, universities and industry, a specialized programme on biopharmaceuticals related regulatory affairs and drug development was designed. Extremely qualified speakers are appointed to provide a training course of highest quality. The utilization of case studies and also the interaction of experts between agencies and corporations provide a unique experience simulating vital aspects of regulatory practice for biopharmaceutical products. These techniques not only permit attendees to achieve theoretical accumulation but additionally the necessary soft skills needed for a regulatory Affairs professional. The European Society of regulatory Affairs conducts an annual meeting regarding regulatory affairs and biopharmacuetics.it additionally organizes several seminars every year on latest trending topics and research associated with regulatory affairs. regulatory affairs is a relatively new profession that developed from the need of governments to protect public health by controlling the safety and efficacy of products in areas together with pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines. The companies liable for the discovery, testing, manufacture and marketing of those products also wish to make sure that they provide products that are safe and make a worthwhile contribution to public health and welfare.